$4.50
+0.16 (+3.57%)
OMSE News30 articles
SpaceX $44.8B Share Unlock Looms as Trading Volume Set to Triple
SpaceX braces for a $44.8 billion share unlock on August 20, 3.3 times Friday's volume. Stock dips 0.9% to $140, but Q2 revenue jumps 92%.
Ondas Rebounds on Tariff News, Q4 Revenue Hurdle Looms
Ondas shares recover after drone tariffs, but Q4 revenue target of $256M is steep. Q2 adjusted EBITDA loss widened.
Live Nation Rises as California Drops Ticket Resale Cap; Federal Fight Looms
Live Nation shares gained 1.5% after California paused a ticket resale cap bill. Federal antitrust challenges remain a bigger overhang.
Capricor Shares Jump as FDA Reviews New Duchenne Data; PDUFA Date Looms
Capricor shares rose 51.7% after the FDA agreed to review new 24-month data for deramiocel, but the stock remains far below its July peak as the Aug. 22 decision date approaches.
Intuitive Machines Tumbles as Q2 Misses, H2 Growth Hurdle Looms
Intuitive Machines stock dropped 8.6% premarket after Q2 revenue missed forecasts and adjusted EBITDA swung to a loss. The company's full-year outlook requires a sharp acceleration in H2 revenue growth.
El Niño Threat Looms Over Starbucks' Margin Recovery as Coffee Costs Surge
Starbucks' margin rebound faces a new threat from a likely strong El Niño and rising coffee costs, even as the stock nears analyst price targets.
Global Markets Mixed as Inflation Data Looms; JPMorgan Raises Singapore Outlook
US futures steady ahead of inflation data. JPMorgan raises Singapore STI target to 7,000. Plug Power, Septerna, and Balfour Beatty see notable moves.
Nebius Shares Surge 5% as $2B H2 Revenue Goal Looms Ahead of Earnings
Nebius (NBIS) shares rose 5% ahead of Q2 earnings, with the company facing a critical test to hit $2 billion in second-half revenue.
ONDS Rises on Israeli Drone Deal, Yet Valuation Looms Large
Ondas shares gained 2.4% to $9.535 following an Israeli drone contract, but the stock's valuation at 10.35x 2026 revenue remains a concern. Q2 earnings are due Thursday.
Alphabet Drops 3.6% as Pixel Event Looms; AI Capex Concerns Persist
Alphabet shares slid 3.6% on Tuesday as tech stocks retreated ahead of the Pixel 11 launch. Investors focus on AI capital spending and Cloud growth sustainability.
Lumentum Stock Holds Steady Ahead of Q4 Report as AI Margin Test Looms
Lumentum shares were stable ahead of its fiscal Q4 report, with options implying a 13% swing. The focus is on margin expansion as revenue approaches $1 billion.
SpaceX Shares Fall Below IPO Price as Lock-Up Expiry Looms
SpaceX shares fell 5.3% to $131.33, dipping under their IPO price, with a 320 million-share lock-up expiry approaching on August 20.
SpaceX Stock Dips as Massive Share Unlock Looms
SpaceX shares dropped 4.5% as a 320-million-share unlock on Aug 20 looms, representing 3.4 days of average volume. Q2 revenue surged 92%.
AST SpaceMobile Stock Climbs on $1.3B Backlog, H2 Revenue Hurdle Looms
AST SpaceMobile shares gained 1.3% to $69.63 after Q2 revenue missed consensus, but contracted backlog rose to $1.30B. The company needs $103.7M-$153.7M in H2 revenue to hit its 2026 target.
CoreWeave Stock Surges 26% as Earnings Test Looms
CoreWeave (NASDAQ:CRWV) shares jump 26% this week as investors await Q2 earnings. The company faces margin pressure and high leverage, with options pricing a 13% move.
Steakholder Foods Soars on Warrant Trigger, Dilution Risk Looms
Steakholder Foods shares skyrocketed 161.6% premarket after warrants became deeply in-the-money, but the rally highlights dilution risks and funding needs.
Ondas Stock Surges 22% as $406M H2 Revenue Hurdle Looms
Ondas (ONDS) shares surged 21.6% last week, but the company must deliver over $406 million in H2 revenue to hit its 2026 target. Q2 earnings Thursday will be pivotal.
Doximity Stock Soars 33% on AI Hopes, but Revenue Gap Looms
Doximity (DOCS) shares surged 33% after fiscal Q1 results, but AI Search revenue remains absent. The company raised revenue guidance while cutting EBITDA outlook, creating a critical test for AI monetization.
Oklo's Test Reactor Goes Critical, But $4.2B Valuation Gap Looms
Oklo's Groves test reactor reached criticality, a key milestone, yet its $7.19B market cap far exceeds cash on hand, underscoring the need for commercial validation.
Oscar Health Stock Surges on Q2 Beat, But H2 Loss Forecast Looms
Oscar Health (OSCR) shares rose 6.6% in premarket trading after Q2 results beat estimates, but the insurer's full-year guidance implies a substantial operating loss in the second half.
Huntington's Valuation Gap Widens as Q4 Synergy Deadline Looms
Huntington Bancshares (HBAN) closed at $17.60, up 0.2%, but trades at a 14% tangible-book discount to peers. Q4 synergy execution is now the key catalyst.
Rain Enhancement Shares Plunge 62% as Nasdaq Compliance Deadline Looms
Rain Enhancement shares dropped 62% from premarket highs, jeopardizing its Nasdaq listing. The company must meet a $35 million market value threshold by August 17.
GameStop Shares Steady After $1.4B Debt Swap; Dilution Looms
GameStop (GME) traded flat after a $1.4B debt exchange, with dilution concerns capping gains. Shares fell 12.25% Monday to $19.06.
Faraday Future Soars 20% on Robot Sales Record, But 2,000-Unit Target Looms
Faraday Future (FFAI) shares surged nearly 20% premarket after its robotics unit reported record July sales. Yet achieving the 2,000-unit annual target demands doubling monthly shipments, raising questions about cash burn and dilution.
Palantir Q2 Report Looms as Commercial Revenue Nears Government Sales
Palantir's Q2 earnings arrive Monday as US commercial revenue nears government sales, with a potential crossover signaling AI-driven growth. Analysts expect modest revenue beat.
Tech Gains Mask Narrow Market as Jobs Report Looms
Stocks closed higher this week, but tech-led gains masked a narrow rally. Investors now await the July jobs report, which could influence Fed rate hike expectations.
Apnimed Surges 56% in Nasdaq Debut as FDA Decision Looms
Apnimed (NASDAQ:APMD) closes its first day up 56% at $25, valuing the company near $1 billion as the FDA reviews its sleep apnea treatment.
Wetour Robotics Soars 145% Before 1-for-100 Reverse Split; Vote on 2 Trillion Share Plan Looms
Wetour Robotics (WETO) surges 145% pre-reverse split; shareholders to vote on 2 trillion share plan and Class B stock with 100 votes per share.
Cycurion Surges 400% on $54.6M Contract, But Cash Crunch Looms
Cycurion shares skyrocketed 400% following a $54.6 million state health-system contract, but liquidity issues and a negative working capital position pose immediate hurdles.
Sandisk's $198B July Plunge: Earnings Hurdle Looms Large
Sandisk shares plummeted 55% in July, erasing nearly $198 billion in market cap, as Q4 EPS consensus rose 5.1% above management's guidance ceiling.